Browsing Tag
NSE
200 posts
HCLTECH near 52-week low after Q4 miss — what the FY27 guidance is really telling the market
HCLTech Q4 FY26 results analysed: $620M AI revenue, margin compression, FY27 guidance and what HCLTECH's near 52-week low signals. Read more.
Hindustan Unilever (NSE: HINDUNILVR): Q4 FY26 results due 30 April with final dividend on the table
Hindustan Unilever (NSE: HINDUNILVR) reports Q4 FY26 results and final dividend on 30 April 2026. Rural recovery, OZiva acquisition, and Unilever-McCormick deal shape the investment case. 158 characters.
HG Infra Engineering (HGINFRA) wins Rs 519cr Mirzapur thermal power railway contract as stock attempts recovery from 57% decline
HG Infra Engineering (HGINFRA) wins Rs 519.33 crore railway civil works order at Adani Power's Mirzapur thermal plant. Analysis of what it means for investors. Read more.
NTPC just hit record capacity additions, signed a nuclear deal with France and still trades at a discount. Worth watching?
NTPC (NSE: NTPC) hit record FY26 capacity additions and signed an EDF nuclear MoU. With â‚ą380 CMP and analyst targets to â‚ą440, here is what retail investors need to know.
Ashok Leyland share price outlook: what next for NSE: ASHOKLEY after the rebound?
Ashok Leyland (NSE: ASHOKLEY) is back in focus after a sharp rebound. Read what comes next, the key catalyst path, and the risks investors should track.
Tata Power (NSE: TATAPOWER): Can the Mundra restart and renewables surge unlock the next leg higher?
Tata Power's Mundra plant restarted April 1 after a nine-month shutdown. With new PPAs, a 23 GW renewable target, and Q4 results due April 26, here's what investors need to know.
Adani Power (NSE: ADANIPOWER): What’s driving the Q4 FY26 earnings moment and the Rs 2 lakh crore expansion bet
Adani Power (NSE: ADANIPOWER) faces Q4 FY26 results on April 28. Here's what the MSEDCL contract, 41.87 GW expansion, and profit decline mean for retail investors.
Wipro (WIT) secures eight-year, $1bn Olam contract and pays $375m for agribusiness IT unit Mindsprint
Wipro secures an $1bn, eight-year Olam Group transformation deal and acquires Mindsprint for $375m. What it means for WIT stock, competitors, and agribusiness IT. Read more.
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Granules India (NSE: GRANULES) exits FDA audit with four observations as regulatory scrutiny intensifies
Granules India's Chantilly facility exits a routine US FDA cGMP audit with four procedural Form 483 observations and no data integrity findings. Read what it means for the GRANULES growth outlook.